VirtaMed Announces New Inclusive Knee Simulation Model

VirtaMed, the world leader in medical simulation training, has announced the release of enhanced simulation training modules for arthroscopic knee surgeries. In a first for VirtaMed, these latest training modules will now be available on simulators with two different skin tones.

“It is important to learn medical skills in a realistic environment, and that means training on simulators that reflect the diversity of both patients and trainee physicians,” said Dr. Raimundo Sierra, founder and CEO of VirtaMed. “VirtaMed is committed to encouraging diversity and inclusion in the education of medical skills, and we believe these values should also be reflected in the simulator hardware. This is just one step in the right direction toward more equitable healthcare education and delivery.”

2005 report released by the Institute of Medicine documented that “racial and ethnic minorities receive lower-quality health care than white people — even when insurance status, income, age and severity of conditions are comparable.” While not referring specifically to surgical outcomes, the report and similar studies have indicated that people of color are less likely to receive effective treatments, due in part to implicit bias from healthcare providers.

In developing the new simulators, VirtaMed collaborated with knee experts Dr. Jacqueline Brady, Dr. Cassandra Lee, and Dr. Patrick Joyner from the AANA Knee Taskforce. VirtaMed and AANA knee experts identified high-priority new cases and features with the most potential impact for training the next generation of surgeons. The VirtaMed ArthroS™ is unique in simulation training as trainees are able to palpate and distract a physical model while at the same time performing a virtual surgery.

The new training options are the most recent in a series of updates stemming from a collaborative agreement between VirtaMed and the AANA to advance and improve arthroscopy surgery skill training and develop standards for proficiency-based training curricula. Since 2018, AANA experts have collaborated with VirtaMed to provide expert input on cases and courses for training on the fundamentals of arthroscopy (FAST), and the knee, shoulder and hip joints.

The new model, as well as additional software upgrades, will be unveiled at this year’s American Academy of Orthopaedic Surgeons (AAOS) conference held in Chicago, March 22-26. 2022. Live demonstrations will be held at booth 1421 and can be reserved at virtamed.com.

Hot this week

Cartessa Aesthetics Partners with Classys to Bring EVERESSE to the U.S. Market

Classys, which is listed on the KOSDAQ, is one of South Korea's most distinguished aesthetic technology manufacturers, with devices distributed in 80+ markets globally. This partnership marks Classys's official entry into the American marketplace, with Cartessa Aesthetics as the exclusive distributor for EVERESSE, launched under the Volnewmer brand in current global markets.

Stryker Launches Next-Generation of SurgiCount+

Now integrated with Stryker's Triton technology, SurgiCount+ addresses two key challenges: retained surgical sponges and blood loss assessment. Integrating these previously separate digital solutions provides the added benefit of a more efficient, streamlined workflow for hospitals notes Stryker.

Nevro Receives CE Mark In Europe for It’s HFX iQ™ Spinal Cord Stimulation System

Nevro notes HFX iQ is the first and only SCS system with artificial intelligence (AI) technology that combines high-frequency (10 kHz) therapy built on landmark evidence that uses ongoing cloud data insights to deliver personalized pain relief

Recor Medical Reports: CMS Grants Distinct TPT Device Code and Category to Recor Medical for Ultrasound Renal Denervation

The approval of TPT offers incremental reimbursement payments for outpatient procedures performed with ultrasound renal denervation for Medicare fee-for-service beneficiaries. It becomes effective January 1, 2025, and is expected to remain effective for up to three years notes Recor Medical.

Jupiter Endovascular Reports | 1st U.S. Patient Treated with Jupiter Shape-shifting Thrombectomy Device

“Navigation challenges during endovascular procedures are often underappreciated and have led to under-adoption of life-saving procedures, such as pulmonary embolectomy. We have purpose-built our Endoportal Control technology to solve these issues and make important endovascular procedures accessible to more clinicians and their patients who can benefit from them,” said Carl J. St. Bernard, Jupiter Endovascular CEO. “This first case in the U.S. could not have gone better, and appears to validate the safety and performance we are seeing in our currently-enrolling European SPIRARE I study.”
Exit mobile version